Acute myocardial infarction associated with prostaglandin E2
Related Experiment Videos
W J Meyer1, S L Benton, T J Hoon
1Division of Maternal-Fetal Medicine, University of Illinois, Chicago 60612.
American Journal of Obstetrics and Gynecology
|August 1, 1991
Abstract:
Prostaglandin E2 is rarely associated with serious maternal side effects when used for second-trimester pregnancy termination. Acute myocardial infarction complicating therapeutic pregnancy termination with prostaglandin E2 in a patient with chronic glomerulosclerosis and severe hypertension is reported.